METHOD FOR TREATING PATIENTS WITH THE DEFECTS OF CARDIAC VALVES

FIELD: medicine, cardiosurgery. ^ SUBSTANCE: it is necessary to carry out surgical correction of myocardial defect and circulation, moreover, in case of the availability of myocardial areas with decreased perfusion being above 50% it is important to fulfill transplantation of antilogous mononuclear...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVYDENKO VLADIMIR VALENTINOVICH, MATJUKOV ANDREJ ALEKSANDROVICH, GRITSENKO VLADIMIR VIKTOROVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, cardiosurgery. ^ SUBSTANCE: it is necessary to carry out surgical correction of myocardial defect and circulation, moreover, in case of the availability of myocardial areas with decreased perfusion being above 50% it is important to fulfill transplantation of antilogous mononuclear fraction of medullary cells into the areas mentioned and, also, into coronary arteries or into aorta- and mammarocoronary bypasses. Autologous mononuclear fraction of medullary cells should be obtained due to separating the cells of bone marrow sampled by puncturing out of the sternum before sternotomy at the volume of 1205 ml. The innovation in question enables to reconstruct myocardial microvascular system. ^ EFFECT: higher efficiency of therapy. ^ 1 cl, 9 dwg, 7 ex